Sparsentan Intermediate: Key Chemical Compound for Advanced Pharmaceutical Synthesis
Unlock breakthroughs in kidney disease treatment with this high-purity pharmaceutical intermediate.
Get a Quote & SampleProduct Core Value
![N-(4,5-Dimethyl-3-Isoxazolyl)-2′-(Ethoxymethyl)-4′-(Hydroxymethyl)-N-(Methoxymethyl)-[1,1'-Biphenyl]](https://www.nbinno.com/webimg/gemini_6881bc9d7b29a_1753332893.png)
N-(4,5-Dimethyl-3-Isoxazolyl)-2′-(Ethoxymethyl)-4′-(Hydroxymethyl)-N-(Methoxymethyl)-[1,1'-Biphenyl]-2-Sulfonamide
This high-quality chemical compound serves as a crucial building block in the synthesis of Sparsentan, a promising therapeutic agent for IgA Nephropathy. Its precise chemical structure and adherence to stringent quality standards ensure reliable outcomes in advanced pharmaceutical research and production.
- Facilitating the chemical synthesis of Sparsentan, a significant development in treating kidney diseases.
- Meeting rigorous quality benchmarks with GMP, ISO 9001, and FDA certifications, ensuring purity and efficacy.
- Available in industrial and laboratory grades to support diverse research and production needs.
- A vital pharmaceutical intermediate for scientific research aiming to develop novel health solutions.
Key Advantages
Purity and Consistency
The production of this sparsentan intermediate adheres to strict quality control measures, guaranteeing a consistent and high-purity product for your pharmaceutical synthesis needs.
Regulatory Compliance
With GMP, ISO 9001, and FDA certifications, this chemical intermediate meets global regulatory standards, simplifying your drug development and approval processes.
Research Enablement
As a critical component in the pharmaceutical synthesis of Sparsentan, this compound empowers scientific research focused on novel kidney disease treatments.
Key Applications
Pharmaceutical Synthesis
Used as a key building block in the complex chemical synthesis of Sparsentan for potential IgA Nephropathy treatments.
Scientific Research
Essential for laboratories and research institutions exploring new therapeutic pathways in nephrology and related health sciences.
Quality Control
Ensuring the reliability and effectiveness of final pharmaceutical products through the use of certified intermediates.
Drug Development
A fundamental component in the drug development pipeline for agents targeting kidney function and disease progression.